Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls

British Journal of Dermatology

Volumn 137, Issue 6, 1997, Pages 921-927

  Gordon, D J ^a   Ostlere, L S ^a   Holden, C A ^a  

^a ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; NEUROPEPTIDE; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031450326     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb01552.x     Document Type: Article

References (26)

1. Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995; 33: 482-96.
2. Wallengren J, Ekman R, Moller H. Substance P and vasoactive intestinal peptide in bullous and inflammatory skin disease. Acta Derm Venereol (Stockh) 1986; 66: 23-8.
3. Coulson I, Holden CA. Cutaneous reactions to substance P and histamine in atopic dermatitis. Br J Dermatol 1990; 122: 343-9.
4. Fjellner B, Hagermark O. Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol (Stockh) 1981; 61: 245-50.
5. Piotrowski W, Devoy MAB, Jordan CC, Foreman JC. The substance P receptor on rat mast cells and in human skin. Agents Actions 1984; 14: 420-4.
6. Pascual DW, Blalock JE, Bost KL. Antipeptide antibodies that recognise a lymphocyte substance P receptor. J Immunol 1989; 143: 3697-702.
7. Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P and somatostatin in immunoglobulin synthesis and proliferation by lymphocytes from Peyer's patches, mesenteric lymph nodes and spleen. J Immunol 1986; 136: 152-6.
8. Wagner F, Fink R, Hart R, Dancyngier H. Substance P enhances interferon gamma production by human peripheral blood mononuclear cells. Regul Peptides 1987; 19: 355-64.
9. Rameshvar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins. J Immunol 1993; 151: 2484-96.
10. Blum AM, Metwali A, Cook G et al. Substance P modulates antigen-induced IFNγ production in murine Schistosomiasis mansoni. J Immunol 1993; 151: 225-33.
11. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241: 1218-21.
12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venerol (Stockh) 1980; 92 (Suppl.): 44-7.
13. Mosmann TR, Chenvinski H, Bond MW et al. Two types of murine helper T cell clone: 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-57.
14. Paliard X, Malefijt RdeW, Yssel H et al. Simultaneous production of IL-2, IL-4 and IFNγ by activated human CD4+ and CD8+ T cell clones. J Immunol 1988; 141: 849-55.
15. Seder RA, Paul WE. Acquisition of lymphokine producing phenotype by CD4+ cells. Annu Rev Immunol 1994; 12: 635-73.
16. Geppert TD, Davies LS, Gur H et al. Accessory signals involved in T-cell activation. Immunol Rev 1990; 117: 5-66.
17. Chan SC, Kim J-W, Henderson WR, Hanifin JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993; 151; 3345-52.
18. Chan SC, Li S-H, Hanifin JM. Increased IL-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993; 100: 681-4.
19. Jujo K, Renz H, Abe J et al. Decreased interferon gamma and increased interleukin 4 production in atopic dermatitis promotes IgE synthesis. J Allergy Clin Immunol 1992; 90: 323-31.
20. Imada M, Estelle F, Simons R et al. Allergen stimulated interleukin 4 and interferon gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls. Immunology 1995; 85: 372-80.
21. Reinhold U, Wehrmann W, Kukel S, Kreysel HW. Evidence that defective interferon gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin Exp Immunol 1990; 79: 374-9.
22. Byron KA, Liberatos S, Varigos GA, Wooton AM. Interferon gamma production in atopic dermatitis: a role for prostaglandins? Int Arch Allergy Immunol 1992; 99: 50-5.
23. Hanifin JM, Chan SC. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis. J Invest Dermatol 1995; 105: 84-8S.
24. Betz M, Fox BS. Prostaylandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146: 108-13.
25. Grewe M, Gyufko K, Schopf K, Krutmann J. Lesional expression of interferon γ in atopic eczema. Lancet 1994; 343: 25-6.
26. Scicchtano R, Biennenstock J, Stanisz AM. In vivo immunomodulation by the neuropeptide substance P. Immunology 1988; 63: 733-5.